Argent Trust Co’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.02M | Buy |
92,526
+3,666
| +4% | +$351K | 0.27% | 88 |
|
|
2025
Q4 | $8.54M | Buy |
88,860
+460
| +0.5% | +$44.7K | 0.29% | 79 |
|
|
2025
Q3 | $8.42M | Buy |
88,400
+2,072
| +2% | +$190K | 0.3% | 72 |
|
|
2025
Q2 | $7.53M | Buy |
86,328
+5,832
| +7% | +$495K | 0.28% | 74 |
|
|
2025
Q1 | $7.23M | Buy |
80,496
+24,476
| +44% | +$2.19M | 0.3% | 74 |
|
|
2024
Q4 | $4.47M | Buy |
56,020
+6,721
| +14% | +$582K | 0.18% | 110 |
|
|
2024
Q3 | $4.44M | Sell |
49,299
-6,130
| -11% | -$516K | 0.18% | 114 |
|
|
2024
Q2 | $4.36M | Buy |
55,429
+4,136
| +8% | +$339K | 0.19% | 108 |
|
|
2024
Q1 | $4.47M | Sell |
51,293
-6,023
| -11% | -$514K | 0.2% | 105 |
|
|
2023
Q4 | $4.72M | Buy |
57,316
+3,269
| +6% | +$249K | 0.23% | 96 |
|
|
2023
Q3 | $4.24M | Sell |
54,047
-1,382
| -2% | -$116K | 0.23% | 96 |
|
|
2023
Q2 | $4.88M | Buy |
55,429
+14,686
| +36% | +$1.26M | 0.26% | 85 |
|
|
2023
Q1 | $3.28M | Buy |
40,743
+1,948
| +5% | +$159K | 0.21% | 112 |
|
|
2022
Q4 | $3.02M | Buy |
38,795
+439
| +1% | +$35.6K | 0.2% | 112 |
|
|
2022
Q3 | $3.1M | Buy |
38,356
+1,824
| +5% | +$164K | 0.22% | 98 |
|
|
2022
Q2 | $3.28M | Sell |
36,532
-326
| -0.9% | -$33K | 0.23% | 101 |
|
|
2022
Q1 | $4.09M | Buy |
36,858
+838
| +2% | +$88.5K | 0.25% | 93 |
|
|
2021
Q4 | $3.73M | Sell |
36,020
-309
| -0.9% | -$35.8K | 0.22% | 102 |
|
|
2021
Q3 | $4.55M | Buy |
36,329
+3,209
| +10% | +$415K | 0.29% | 86 |
|
|
2021
Q2 | $4.11M | Buy |
33,120
+1,729
| +6% | +$217K | 0.27% | 92 |
|
|
2021
Q1 | $3.71M | Buy |
31,391
+232
| +0.7% | +$27.2K | 0.26% | 92 |
|
|
2020
Q4 | $3.65M | Sell |
31,159
-37
| -0.1% | -$4.07K | 0.28% | 82 |
|
|
2020
Q3 | $3.24M | Sell |
31,196
-7,643
| -20% | -$768K | 0.29% | 81 |
|
|
2020
Q2 | $3.56M | Buy |
38,839
+128
| +0.3% | +$12.3K | 0.33% | 69 |
|
|
2020
Q1 | $3.49M | Sell |
38,711
-3,317
| -8% | -$353K | 0.39% | 63 |
|
|
2019
Q4 | $4.77M | Sell |
42,028
-713
| -2% | -$78.2K | 0.42% | 65 |
|
|
2019
Q3 | $4.64M | Buy |
42,741
+5,065
| +13% | +$528K | 0.45% | 59 |
|
|
2019
Q2 | $3.67M | Buy |
37,676
+1,842
| +5% | +$168K | 0.37% | 67 |
|
|
2019
Q1 | $3.26M | Buy |
35,834
+135
| +0.4% | +$12.1K | 0.34% | 74 |
|
|
2018
Q4 | $3.25M | Buy |
35,699
+29,246
| +453% | +$2.73M | 0.38% | 69 |
|
|
2018
Q3 | $635K | Buy |
6,453
+787
| +14% | +$72.8K | 0.07% | 227 |
|
|
2018
Q2 | $484K | Buy |
+5,666
| New | +$473K | 0.06% | 266 |
|
|
2017
Q4 | – | Sell |
-3,763
| Closed | -$292K | – | 266 |
|
|
2017
Q3 | $292K | Buy |
+3,763
| New | +$312K | 0.12% | 205 |
|
|
2016
Q4 | – | Sell |
-3,516
| Closed | -$304K | – | 262 |
|
|
2016
Q3 | $304K | Buy |
+3,516
| New | +$306K | 0.13% | 198 |
|
|
2016
Q2 | – | Sell |
-4,412
| Closed | -$331K | – | 257 |
|
|
2016
Q1 | $331K | Buy |
+4,412
| New | +$332K | 0.16% | 179 |
|
|
2015
Q4 | – | Sell |
-3,006
| Closed | -$201K | – | 243 |
|
|
2015
Q3 | $201K | Sell |
3,006
-502
| -14% | -$37K | 0.11% | 211 |
|
|
2015
Q2 | $260K | Buy |
+3,508
| New | +$268K | 0.13% | 203 |
|
Other funds holding MDT
VCM
VPM
Argent Trust Co's MDT Position: Q1 2026 in Review
Argent Trust Co increased its Medtronic (MDT) stake by 4.1% in Q1 2026, buying an estimated $351K and bringing the position to 92,526 shares worth $8.02M. The position accounts for 0.27% of the portfolio, ranked #88.
Argent Trust Co first reported a position in MDT in Q2 2015 and has held it in 37 quarters since. The position peaked at $8.54M in Q4 2025. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Argent Trust Co held 92,526 shares of Medtronic worth $8.02M as of Q1 2026.
- Argent Trust Co bought 3,666 Medtronic shares in Q1 2026, an estimated $351K.
- Medtronic made up 0.27% of Argent Trust Co's portfolio in Q1 2026, its #88 holding.
- Argent Trust Co first reported a position in Medtronic in Q2 2015 and has held it in 37 quarters since.
- Argent Trust Co's Medtronic position peaked at $8.54M in Q4 2025.
- 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.